Search alternatives:
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
5821
-
5822
Molecular Insights on Methane Hydrate Dissociation in the Presence/Absence of Poly-<i>N-</i>vinylcaprolactam: Effects of Gas Saturation and Nanobubbles
Published 2025“…For the systems with PVCap, it was found that PVCap has a certain promoting effect on methane hydrate dissociation; the promotion effect decreased with the increase in methane content in the initial liquid phase. …”
-
5823
Molecular Insights on Methane Hydrate Dissociation in the Presence/Absence of Poly-<i>N-</i>vinylcaprolactam: Effects of Gas Saturation and Nanobubbles
Published 2025“…For the systems with PVCap, it was found that PVCap has a certain promoting effect on methane hydrate dissociation; the promotion effect decreased with the increase in methane content in the initial liquid phase. …”
-
5824
Molecular Insights on Methane Hydrate Dissociation in the Presence/Absence of Poly-<i>N-</i>vinylcaprolactam: Effects of Gas Saturation and Nanobubbles
Published 2025“…For the systems with PVCap, it was found that PVCap has a certain promoting effect on methane hydrate dissociation; the promotion effect decreased with the increase in methane content in the initial liquid phase. …”
-
5825
-
5826
-
5827
Imaging CDK4/6 Broaden Options of Breast Cancer Diagnostics with Positron Emission Tomography
Published 2025“…This study developed a novel PET radiotracer to screen breast cancer patients sensitive to CDK4/6 inhibitors, guiding personalized treatment. …”
-
5828
Imaging CDK4/6 Broaden Options of Breast Cancer Diagnostics with Positron Emission Tomography
Published 2025“…This study developed a novel PET radiotracer to screen breast cancer patients sensitive to CDK4/6 inhibitors, guiding personalized treatment. …”
-
5829
Imaging CDK4/6 Broaden Options of Breast Cancer Diagnostics with Positron Emission Tomography
Published 2025“…This study developed a novel PET radiotracer to screen breast cancer patients sensitive to CDK4/6 inhibitors, guiding personalized treatment. …”
-
5830
Imaging CDK4/6 Broaden Options of Breast Cancer Diagnostics with Positron Emission Tomography
Published 2025“…This study developed a novel PET radiotracer to screen breast cancer patients sensitive to CDK4/6 inhibitors, guiding personalized treatment. …”
-
5831
Imaging CDK4/6 Broaden Options of Breast Cancer Diagnostics with Positron Emission Tomography
Published 2025“…This study developed a novel PET radiotracer to screen breast cancer patients sensitive to CDK4/6 inhibitors, guiding personalized treatment. …”
-
5832
Imaging CDK4/6 Broaden Options of Breast Cancer Diagnostics with Positron Emission Tomography
Published 2025“…This study developed a novel PET radiotracer to screen breast cancer patients sensitive to CDK4/6 inhibitors, guiding personalized treatment. …”
-
5833
Imaging CDK4/6 Broaden Options of Breast Cancer Diagnostics with Positron Emission Tomography
Published 2025“…This study developed a novel PET radiotracer to screen breast cancer patients sensitive to CDK4/6 inhibitors, guiding personalized treatment. …”
-
5834
-
5835
-
5836
-
5837
-
5838
-
5839
-
5840